7th HPAPI Summit

Memo

The HPAPI Summit brings together perspectives throughout the value chain from bench to outsource, providing you with a unified outlook on the latest developments in highly potent manufacturing.



As compounds become increasingly potent, the need for harmonization among distinct groups within organizations around key challenges is more acute than ever before.



By involving multiple perspectives from companies of different size and experience in the field, the HPAPI Summit will enable you to understand how you can implement safe and robust practices in your own organization.



Incorporating insights from Genentech, Pfizer, Vertex, SafeBridge and Boehringer Ingelheim, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly, safely and cost-effectively.



Group booking discounts and start-up biotech rates are available upon request. Email This email address is being protected from spambots. You need JavaScript enabled to view it. to enquire about your eligibility.



URLs:

Brochure: https://go.evvnt.com/204863-1?pid=5569,

Booking: https://go.evvnt.com/204863-2?pid=5569,



Date and Time: On Tuesday June 19, 2018 at 8:00 am ends Thursday June 21, 2018 at 6:00 pm,



Price:

Conference + 3 Workshops: USD 4596,

Conference + 2 Workshops: USD 3997,

Conference + 1 Workshops: USD 3398,

Conference Only: USD 2799,



Venue details: Aloft Boston Seaport, 401-403 D St, Boston, 02210, United States,



Speakers: Marc Abromovitz (Novartis), Richard Wooster (Tarveda Therapeutics), Reinhold Maeck (Boehringer Ingelheim), Paul Richards (Biogen), Jacqui Van Sipe (Vertex), Samuel Baron (SK Biotech Ireland), Jay Brown (Alkermes), Dean Calhoun (Affygility Solutions), Scott Duncan (Stealth Biotherapeutics), Timothy Maher (Merck), Evan Thackaberry (Ra Pharmaceuticals), John Roosa (Merck) and Many More!